COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,312 Articles (22,772 medRxiv, 8,540 bioRxiv)

Most recent first Page 1: Articles 1-10  | Next

Circadian immunometabolic states impart a temporal response to SARS-CoV-2 spike proteins in mammalian macrophages
Buel, S. M., Balaraman, J., Jankowski, M. S., Hixson, K. K., Gao, Y., Kim, Y.-m., Munoz, N., Kyle, J. E., Lipton, M. S., Nicora, C. D., Piehowski, P. D., Baker, S. E., Hurley, J. M.
10.64898/2026.02.24.707668 — Posted: 2026-02-25
Identification of MED13 and DDX60 as critical host factors for SARS-CoV-2 infections
Kwon, H., Wai, S. T., Michlits, G., Dyczynski, M., Markovic, A., Rocha Berger, A. S. B., JOHN, L., Horn, M., Weber, F., Penninger, J. M., Monteil, V., Mirazimi, A.
10.64898/2026.02.25.707691 — Posted: 2026-02-25
AVE0991, a Mas receptor agonist, increases influenza and COVID-19 severity in vivo.
Wu, M., Sng, J. D. J., Noye, E. C., McCallum, G., Bielefeldt-Ohmann, H., Foo, C. X., Ronacher, K., Chew, K. Y., Short, K. R.
10.64898/2026.02.23.707600 — Posted: 2026-02-24
Genetic Evidence Indicates the Evolutionary Importance of the SARS-CoV-2 ORF9b protein
Hisner, R., Martin, D. P.
10.64898/2026.02.23.707522 — Posted: 2026-02-24
Genomic Evolution of SARS-CoV-2 Delta Variants Pre- and Post-Omicron Emergence using Alignment-free Machine Learning models
Sankar, S., Anandharaman, K., Selvam, P., Jayaraman, A., Jayakumar, D., Sivadoss, R., Esaki Muthu, S., Velu, V., Larsson, M., Balakrishnan, P.
10.64898/2026.02.20.706927 — Posted: 2026-02-23
PFOA induced metabolic and immune perturbations in a SARS-2 infection model
Lanier, D. N., Rowe Haas, D., Uchimiya, M., Jones, C., Johnson, S., Sakamoto, K., Chappel, J. R., Fry, A. N., Leach, F. E., DeWitt, J., Woodlief, T., Gaul, D. A., Baker, E. S., Fernandez, F. M., Tompkins, S. M., Edison, A. S.
10.64898/2026.02.21.707085 — Posted: 2026-02-23
TMPRSS2 reduces antibody recognition of SARS-CoV-2 spike
Cottignies-Calamarte, A., De Cruz, A., Planchais, C., Porrot, F., Krzypow, M., Jungbauer-Groznica, M., Thuillier, E., Wileveau, A., Staropoli, I., Guivel-Benhassine, F., Rosenbaum, P., Fernandez, I., Rey, F. A., Buchrieser, J., Trouillet-Assant, S., Mouquet, H., Schwartz, O., Bruel, T.
10.64898/2026.02.17.706397 — Posted: 2026-02-20
The buried S2 apex of SARS-CoV-2 spike elicits an immunodominant germline-restricted public antibody response
Park, S., Mischka, J., Okba, N., Abbad, A., Yuan, M., Srivastava, K., Gleason, C., Mulder, L. C. F., Copps, J., Saam, K., Bangaru, S., Krammer, F., Wilson, I. A., Simon, V., Ward, A. B.
10.64898/2026.02.18.706653 — Posted: 2026-02-19
Antibody Responses Against Coronaviruses in the Wuhan Population
Zhou, S., Liu, C., Liu, W., Cai, K., Lan, K., Zhu, C., Wang, Q., Liu, L.
10.64898/2026.02.15.705976 — Posted: 2026-02-17
Cross-reactivity of SARS-CoV-2-specific T cells against tumor-associated antigens via molecular mimicry
Ragone, C., Mauriello, A., Cavalluzzo, B., Mangano, S., Cembrola, B., Ciotola, N., Tagliamonte, M., Buonaguro, L.
10.64898/2026.02.16.706083 — Posted: 2026-02-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).